For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a ...
Rowan Street unpacks Tesla’s bold 2025 CEO award, tying Elon Musk’s pay to $8.5T goals in AI, energy, and robotics. See why ...
For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a ...
SDSC provides high-performance computing and data infrastructure that support researchers doing molecular modeling and ...
Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...
Every cell in the body has the same DNA, but different cell types—such as muscle or brain cells—use different parts of it.
Tested in animal models of acute myeloid leukemia, the new nanomedicine was dramatically more effective while also less toxic ...
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...
MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...
MASPIN (“tumor suppressor shield”): MASPIN is a natural defense protein that blocks tumor invasion, regulates cell migration and angiogenesis, promotes apoptosis, and enhances treatment sensitivity.
MIAMI, FLORIDA / ACCESS Newswire / October 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results